The new combination of drugs was developed by Professor Peter Kremsner of the Tübingen Institute of Tropical Medicine and the company DMG Deutschen Malaria GmbH. The study was conducted at the Centre de Recherches Médicales de Lambaréné (CERMEL) in the African country of Gabon.
“The substance was originally extracted from Streptomyces lavendulae and today can be produced synthetically. It blocks a metabolic pathway for the production of Isoprenoid in the malaria pathogen. This makes the malaria pathogen unable to metabolize or reproduce,” Professor Peter Kremsner explained. treatments.The new combination meets WHO guidelines for combination therapies, the requirements for a fast and effective treatment of the acute phase of infection and for protection against relapse due to reappearance of the infection. The researchers also say the effective mechanism helps to delay the formation of a possible resistance. Tropical diseases were studied in Tübingen as early as the 19th century. Peter G. Kremsner has been the most cited scientist of Germany in this field for two decades.